A detailed history of Massachusetts Financial Services CO transactions in Veracyte, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 9,251 shares of VCYT stock, worth $288,076. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,251
Previous 9,526 2.89%
Holding current value
$288,076
Previous $324,000 12.96%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

SELL
$31.92 - $44.4 $8,778 - $12,210
-275 Reduced 2.89%
9,251 $366,000
Q3 2024

Nov 12, 2024

BUY
$21.0 - $35.25 $200,046 - $335,791
9,526 New
9,526 $324,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.23B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.